We are looking for children 2–17 years of age to join a study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or moderate to severe ulcerative colitis (including associated symptoms such as cramps, loss of appetite, diarrhea, weight loss and/or anemia), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the UC studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited so act quickly.
